WO1998058990A1 - A hydrophilic coating and a method for the preparation thereof - Google Patents
A hydrophilic coating and a method for the preparation thereof Download PDFInfo
- Publication number
- WO1998058990A1 WO1998058990A1 PCT/DK1998/000265 DK9800265W WO9858990A1 WO 1998058990 A1 WO1998058990 A1 WO 1998058990A1 DK 9800265 W DK9800265 W DK 9800265W WO 9858990 A1 WO9858990 A1 WO 9858990A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coating
- hydrophilic
- optionally
- hydrophilic coating
- crosslinking
- Prior art date
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 129
- 239000011248 coating agent Substances 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims description 35
- 238000002360 preparation method Methods 0.000 title claims description 18
- 238000004132 cross linking Methods 0.000 claims abstract description 38
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 35
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 35
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 34
- 239000000758 substrate Substances 0.000 claims abstract description 33
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920001577 copolymer Polymers 0.000 claims abstract description 15
- 239000002987 primer (paints) Substances 0.000 claims description 36
- 229920000642 polymer Polymers 0.000 claims description 31
- 229920006395 saturated elastomer Polymers 0.000 claims description 16
- 239000003999 initiator Substances 0.000 claims description 13
- 238000007598 dipping method Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 229940068984 polyvinyl alcohol Drugs 0.000 claims description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920008347 Cellulose acetate propionate Polymers 0.000 claims description 3
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 238000005299 abrasion Methods 0.000 abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 28
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 26
- 239000010410 layer Substances 0.000 description 19
- 239000004202 carbamide Substances 0.000 description 13
- 229920001477 hydrophilic polymer Polymers 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000011877 solvent mixture Substances 0.000 description 12
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- 229920000915 polyvinyl chloride Polymers 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- -1 for dialysis Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 238000009740 moulding (composite fabrication) Methods 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 125000002348 vinylic group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009888 wet rendering Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/0427—Coating with only one layer of a composition containing a polymer binder
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/043—Improving the adhesiveness of the coatings per se, e.g. forming primers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/046—Forming abrasion-resistant coatings; Forming surface-hardening coatings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/056—Forming hydrophilic coatings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2327/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers
- C08J2327/02—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers not modified by chemical after-treatment
- C08J2327/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers not modified by chemical after-treatment containing chlorine atoms
- C08J2327/06—Homopolymers or copolymers of vinyl chloride
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2475/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
Definitions
- the present invention relates to a hydrophilic coating and to a method for the preparation thereof. Furthermore, the invention relates to a medical device provided with such a hydrophilic coating and a method for providing a medical device or other product with a hydrophilic coating as well as the use of a polymer containing a hydrophilic reactive group for the preparation of a medical device or instrument comprising a hydrophilic coating being crosslinked.
- a hydrophilic coating according to the invention may be used for coating the surface or a part thereof of a wide range of products in order to impart give the surface a low friction.
- products which may be provided with a surface having a low friction when wet are medical instruments such as catheters, endo and laryngoscopes, tubes for feeding, or drainage or endotracheal use, condoms, barrier coatings, e.g. for gloves, wound dressings, contact lenses, implantates, extracorporeal blood conduits, membranes e.g. for dialysis, blood filters, devices for circulatory assistance, packaging for foodstuff, razor blades, fishermen's net, conduits for wiring, water pipes having a coating inside, sports articles, cosmetic additives, mould release agents, and fishing lines and nets.
- hydrophilic coatings on medical devices has become a very important method to improve biocompatibility between living tissue and the medical device. Another important property of hydrophilic coatings is to reduce the friction and to render biomedical devices slippery when wet.
- Medical devices like catheters, guide-wires, endoscopes etc. are often sliding in direct contact with the surface of living tissue when in use.
- Catheters and guide wires may e.g. be introduced into the blood vessels or a catheter for intermittent catherisation of the bladder is introduced through the urethra and withdrawn later after emptying the bladder when performing intermittent catherisation or after some time when performing more or less permanent catherisation.
- the medical device is sliding in direct contact with a physiological surface, the walls of the blood vessels or the mucosa of the urethra, respectively.
- Hydrophilic coatings having very low wet friction coefficient have been applied to the surface of the medical devices.
- Hydrophilic coatings having a low friction coefficient when wet typically comprise hydrophilic polymers such as polyvinylpyrrolidone (PVP), poly- carboxyl acids, esters, salts and amides of poly(meth)acrylic acid, copolymers of poly (methyl vinyl ether/ maleic anhydride) and polyglycols like polyethylenegly- col (PEG).
- PVP polyvinylpyrrolidone
- PEG polyethylenegly- col
- the first three types of hydrophilic coatings have several disadvantages: they have low abrasion resistance giving the devices a short effective life time. A considerable amount of polymeric residuals is released at the site where it is introduced and at the same time, this loss of polymeric material rapidly increases the friction coefficient. This abrasion or dissolution may even be so pronounced that the reduction of the friction is not effective during all of the service period of the medical device and the low friction may even have vanished when the device is to be retracted.
- the fourth method involves the use of chemically reactive hydrophilic polymers which are chemically bonded to substrates or primers containing e.g. aldehyde, epoxy or isocyanate groups.
- the fourth coating method suffers from the drawback of the use of toxic reactive materials and in order to avoid a residual toxic effect there is a demand of long reaction times and eventually washing steps in the process.
- US patent No. 4,373,009 discloses that a hydrophilic layer is formed on a substrate, e.g. wound drains, catheters, surgical tools and arte- ovenous shunts, by binding unreacted isocyanate groups on the substrate surface and treating the surface with a hydrophilic copolymer made from vinyl-pyrrolidone monomers and monomers containing an active proton adapted to form covalent bonds with the isocyanate.
- EP 0 166 998 B1 a medical instrument having a surface having a reactive functional group covalently bonded with a water- soluble polymer of a cellulose polymer, maleic anhydride polymer, polyacryla- mide or a water-soluble nylon (deriv.) and having lubricity when wetted.
- the substrate is treated with a solution of a compound containing the reactive functional group so that an undercoat is formed which contains this group. This is then coated with the water-soluble polymer which bonds to the functional group.
- European patent application No. EP 0 289 996 A2 discloses a method for form- ing and applying a hydrophilic coating to a moulding in which process a solution containing a water-soluble polymer, more particularly polyvinylpyrrolidone or a copolymer thereof, one or more radically polymerisable vinyl monomers and a photo initiator is applied to the moulding and the applied solution is exposed to an UV radiation for curing purposes.
- a water-soluble polymer more particularly polyvinylpyrrolidone or a copolymer thereof, one or more radically polymerisable vinyl monomers and a photo initiator
- the hydrophilic polymers are typically polymerised from the corresponding monomers directly onto the surface of the medical device, giving a thin and uniform coating
- this method needs even more expensive process equipment and process control to avoid residual toxic monomers than the other methods
- WO 89/09246 discloses solid shaped structures having a surface coated with crosslinked hydrophilic polymer, the coating being durable and exhibiting a low coefficient of friction when wet
- the hydrophilic polymer may e g be optionally substituted polyvinylpyrrohdones or other hydrophilic polymers or mixtures thereof
- the coatings may be crosslinked using UV light in the presence of UV light-activated free radical initiators or using electron beam radiation It is stated that the degree of crosslinking is critical and is controlled by the operating conditions chosen and that too much crosslinking reduces or completely eliminates the low friction surface property, and too little crosslinking negatively affects the du- rability of the coating
- the present invention relates to a hydrophilic coating comprising a cross-linked polyvinylpyrrolidone.
- the invention also relates to a medical device or other product provided with a hydrophilic coating comprising cross-linked polyvinylpyrrolidone.
- the invention relates to a method for the preparation of a medical device comprising a hydrophilic coating comprising a cross-linked polyvinylpyrrolidone.
- the invention relates to the use of polyvinylpyrrolidone for the preparation of a medical device or instrument comprising a cross-linked hydrophilic coating.
- the present invention relates to a hydrophilic coating comprising a cross-linked polyvinylpyrrolidone or copolymer containing N-vinylpyrrolidone, said coating having a higher degree of cross-linking in the parts near the substrate.
- N-vinylpyrrolidone and copolymers containing N-vinylpyrrolidone and optionally a hydrophilic reactive prepolymer having vinylic unsaturation may be polymerised in situ using UV light in the absence of any photo initiator for forming a hydrophilic coating on a substrate, especially a medical device, showing a very high resistance against solution and/or abrasion and a low frictional coefficient when wet.
- the polyvinylpyrrolidone has a molecular weight >100,000 giving the desired properties of the final coating.
- the molecular weight may e.g. be from 300,000 to 800,000 and is preferably about 500,000.
- a saturated polymer not taking part in the cross-linking is present.
- Such saturated polymer is used for controlling the hydrophilic properties of the hydrophilic coating.
- a saturated polymer is preferably a hydrophilic saturated polymer.
- Hydrophilic saturated polymers are preferably selected from polysaccharides, polyvinyl pyr- rolidone, polyvinyl alcohol, polyacrylic acid, polyethylene glycol and copolymers and blends of these.
- the cross-linked coating of the invention preferably contains carboxymethylcellulose, cellulose acetate, cellulose acetate propionate, poly (methyl vinyl ether/ maleic anhydride), poly (meth)acrylic acid, polethylenglycols (PEG), polyamides, polyacrylic amides, poly vinyl alcohol which are physically bonded by entanglement in the crosslinked network.
- the coatings comprise an antibacterial agent such as a silver salt, e g silver sulphadiazme, an acceptable iodine source such as povidone iodine (also called polyvinylpyrrolidone iodine), chlorhexidine salts such as the gluconate, acetate, hydrochloride or the like salts or quaternary antibacterial agents such as benzalkonium chloride or other antiseptics or antibiotics Antibacterial agents reduces the risk of infection, especially when performing urodynamic examinations
- an antibacterial agent such as a silver salt, e g silver sulphadiazme
- an acceptable iodine source such as povidone iodine (also called polyvinylpyrrolidone iodine)
- chlorhexidine salts such as the gluconate, acetate, hydrochloride or the like salts
- quaternary antibacterial agents such as benzalkonium chloride or other antiseptics or antibiotics
- the invention relates to a method for the preparation of a medical device having a cross-linked hydrophilic coating comprising polyvmylpyr- rolidone or a copolymer of N-vinyl pyrrolidone, and optionally one or more saturated polymers, which method comprises dipping the device in a solution containing a polymer containing N-vinylpyrrolidone, and optionally one or more saturated polymers, optionally drying the coating and exposing the coated device to a UV light source for crosslinking
- the device is dipped in a first solution containing a polymer containing N-vinylpyrrolidone, optionally one or more saturated polymers forming a primer coating, optionally drying the primer coating, dipping the device in a second solution containing a polymer containing N- vinylpyrrohdone, optionally one or more saturated polymers, optionally drying the coating and exposing the coated device to a UV light source for crosslinking
- the primer coating is crosslinked by exposure to UV light before dipping the device in the second solution which enables a high degree of crosslinking of the primer coating reducing the swelling end increasing the wearing qualities and hence, the durability of the coating
- the primer coating comprises a photo initiator which, together with PVP being partially swelled into the material of the device before crosslinking gives rise to a good physical and maybe even chemical binding further increasing the durability of the coating It has surprisingly been found that PVP coatings crosslinked through exposure to UV light have an excellent adherence to many polymeric substrates and therefore highly crosslinked PVP coatings in this invention are used as a primer for a topcoat of less crosslinked PVP
- the cross- linked hydrophilic coating comprises coating polyv ⁇ nylpyrrol ⁇ done(PVP) or N- vinylpyrro done copolymers onto a primer containing polyvinylpyrrolodene and a photoinitiator
- the poly- mer comprising N-vinylpyrrolidone is coated on a primer coating comprising a mixture of polyvinylpyrro dene and a hydrophobic oligome ⁇ c photoinitiator polymer which form an interpenetrating primer coat
- photoinitiators When using photoinitiators in the primer coating layer, it especially preferred to use photo initiators having two or three UV-functional groups giving rise to a more heavy and durable crosslinking thereof
- hydrophilic coating of the invention may be attached directly to a substrate or, in some cases, it will be preferred to apply a primer coat on the substrate before applying the hydrophilic surface coating
- the hydrophilic coating of the invention may be attached directly to a sub- strate without applying a primer coat on the substrate
- the substrate may alternatively be coated with a primer coat or primer system first for improving the bonding of the hydrophilic coating to the substrate before applying the hydrophilic surface coating
- a primer coat may be a primer coat known per se and conventionally used for hydrophilic coatings for medical devices, typically an polyurethane base coat of- ten used for PVC substrates or metals for guide wires or polyolefins or acrylates
- the hydrophilic polymers can easily be coated onto the substrate by any means known per se and reacted with the substrate or a primer
- the not crosslinked hydrophilic polymer may e g be applied to the substrate by spray coating, dipping, rolling etc in the form of a solution in water, or a solvent or a mixture thereof or as a dispersion in water
- Solvents for dissolving the hydrophilic prepolymers may for example be water, lower alkanols such as methanol, ethanol, isopropanol, keto alcohols such as di- acetone alcohol, ketones such as acetone, methyl ethyl ketone (MEK), cyclohex- anone, esters such as ethyl acetate, ethyl lactate, ether alcohols such as glycol ethers, polyethylene glycol 400, di and tnethylene glycol, lactones such as gamma-butyrolactone, lactams such as 2-pyrrol ⁇ done, N-methyl-2-pyrrol ⁇ done, N-vinyl-pyrrolidone, amines, ethers, hydrocarbons and/or chlorinated hydrocarbons
- solvent or solvent mixture is easily chosen by the person skilled in the art after routine experiments
- the chemical bonding to the substrate or to the primer can be effected through activation of an UV-initiator
- the reactions which cause polymerisation and crosslinking can be obtained by using UV-light and UV-light activated free radical initiators and optionally co-initiators or accelerators, ionising radiation typically gamma radiation, electron beam radiation and X-ray, or by plasma treatment, ozone and corona or by thermal or catalyst activated free radical initiators such as peroxides and azo compounds
- UV-light and UV-light activated free radical initiators and optionally co-initiators or accelerators ionising radiation typically gamma radiation, electron beam radiation and X-ray, or by plasma treatment, ozone and corona or by thermal or catalyst activated free radical initiators such as peroxides and azo compounds
- photoinitiators gives a high crosslink density and polymeric photoinitiators are preferred because their tendency to migrate is extremely low.
- ESACURE KIP 150 which is an oligo (2-hydroxy-2-methyl-1-(4-(1-methylvinyl)phenyl)propanone) or in other words a 2-hydroxy-2-methylpropiophenone modified oligo-alfa-methylstyrene are preferred because cleavage caused by exposure to UV light only forms residuals as acetone and 2-propanol which easily evaporates.
- Polymeric photoinitiators based on 2-hydroxy-2-methylpropiophenone modified vinylic-, acrylic- or methacrylic monomers or polymers has also been found to give high crosslinking densities in PVP coatings.
- Polymeric photoinitiator can also be used in the topcoat composition but are preferred only in the primer coat.
- Photo initiators will normally be present in an amount from 0.1 to 10%, preferably from 0.1 to 7% giving a suitable degree of bonding and crosslinking to obtain a coating being easy to wet and showing a suitably low friction.
- UV light sources which emit UV light with a wave length below 400 nm, preferably between 100 and 350 nm has been found to enablecuring.
- the substrate may e.g. be metals, ceramics, plastics materials or polymers such as PVC, polyurethanes, polyolefins, EVA copolymers, polyesters or polyacrylates.
- the coatings of the invention may comprise an osmolality increasing agent such as urea, sodium chloride and/or any salt or organic low molecular weight com- pound being physiological acceptable and non-irritating for adjusting the ion strength of the coating approximately to the physiological range, the coating preferably being isotonic in use.
- an osmolality increasing agent such as urea, sodium chloride and/or any salt or organic low molecular weight com- pound being physiological acceptable and non-irritating for adjusting the ion strength of the coating approximately to the physiological range, the coating preferably being isotonic in use.
- the added amount may vary within very broad limits.
- the coatings according to the invention may comprise from about 0.1 % to about 60% and more preferred from 2 to 30% urea.
- a rapid partial solubility is obtained giving a rapid formation of a slippery surface.
- the coating of the invention may also, if desired, comprise plasticizers such as diethylene glycol, glycerol, phthalates, sorbitol or the like.
- inhibitors such as quinones may be added as polymerisation inhibitors.
- agents for decrease of tackiness such as carboxymethylcellulose, cellulose acetate, cellulose acetate propionate, poly (methyl vinyl ether/ maleic anhydride) and polycarboxylates. may be added, if desired.
- pharmaceutically active compounds such as antimicrobial agents or antithrombogenic agents may be added to the composition
- the coatings of the invention comprise an antibac- tenal agent such as a silver salt, e g silver sulphadiazine, an acceptable iodine source such as povidone iodine (also called polyvinylpyrrolidone iodine), chlor- hexidine salts such as the gluconate, acetate, hydrochloride or the like salts or quaternary antibacterial agents such as benzalkonium chloride or the like
- an antibac- tenal agent such as a silver salt, e g silver sulphadiazine, an acceptable iodine source such as povidone iodine (also called polyvinylpyrrolidone iodine), chlor- hexidine salts such as the gluconate, acetate, hydrochloride or the like salts or quaternary antibacterial agents such as benzalkonium chloride or the like
- Indicators for pH or antibodies e g monoclonal antibodies for specific proteins, may also be enclosed in the hydrophilic coatings of the invention
- the invention relates to a medical device or other product provided with a hydrophilic coating comprising cross-linked polyvinylpyrrolidone, said coating having a higher degree of cross-linking in the parts near the substrate
- the invention relates to the use of polyvinylpyrrolidone for the preparation of a medical device or instrument comprising a cross-linked hydrophilic coating said coating having a higher degree of cross-linking in the parts near the substrate
- the hydrophilic coating has a higher degree of cross-linking in the parts near the substrate 1 which may be obtained by applying two layers, the innermost of which comprises PVP and an accelerator, and the outermost of which comprising pure PVP.
- Polyvinylpyrrolidone PVP K 90 available from ISP Inc. having a molecular weight 630,000.
- Ethanol Absolute Alcohol.
- Gamma butyrolactone Gamma-butyrolactone from International Speciality Products.
- UV catalyst ESACURE KIP 150 from Lamberti SpA.
- the tubes or catheters were cut in lengths of 10 cm and fixed on a stainless steel plate with two stainless steel rods as shown in ASTM D 1894 - 93.
- the rods had diameters comparable with the inner diameter of the tubes or catheters to keep their shape even when heavy sledges were placed upon them.
- the friction was determined after wetting by dipping in water for 1 minute.
- the pulling force from the sledge was measured in Newtons.
- PVP K 90 5 parts was dissolved in 95 parts of a ethanol/gamma butyrolactone (85/15) solvent mixture. PVC catheters were dipped in the solution, dried for 30 minutes at 70°C and exposed to a UV light having a wave length between 200 and 300 nm for 6 minutes.
- the catheter became lubricious in wet condition and had a high abrasion resistance.
- PVP K 90 5 parts was dissolved in 95 parts of an ethanol/gamma butyrolac- tone (85/15) solvent mixture. Polyurethane tubes were dipped in the solution, dried for 30 minutes at 70°C and exposed to a UV light with a wave length between 200 and 300 nm for 6 minutes.
- the tubes showed a low friction coefficient and a high abrasion resistance when abraded in water.
- PVP K 90 and 0.05 parts of ESACURE KIP 150 were dissolved in 94.95 parts of an ethanol/gamma butyrolactone (15/85) solvent mixture.
- PVC catheters were dipped in the solution and dried 1 minute at ambient temperature and then dipped in the PVP-solution used in Example 1 The catheters were further dried for 30 minutes at 70°C and exposed to UV-light at a wave length range between 200 and 300 nm for 5 minutes
- PVP K 90 and 0,05 parts of ESACURE KIP 150 were dissolved in 94,95 parts of an ethanol/gamma butyrolactone solvent mixture
- PVC-catheters were dipped in the solution and dried 1 minute at ambient temperature and then dipped in a PVP-solution containing 5 parts of PVP, 1 part of urea and 94 parts of an ethanol/gamma butyrolactone (85/15) solvent mixture
- the catheters were further dried for 30 minutes at 70°C and exposed to UV-light having a wave length range between 200 and 300 nm for 5 minutes
- the friction coefficient of the hydrophilic coating was lower as compared to the friction coefficient of coatings prepared by a single as disclosed in Example 1 , 2 and the coating prepared by a double dipping procedure as disclosed in Example 3
- PVP K 90 5 parts of PVP K 90, 1 part hydroxypropylcellulose and 0 05 parts of ESACURE KIP 150 were dissolved in 93 95 parts of an ethanol/gamma butyrolactone (15/85) solvent mixture
- PVC catheters were dipped in the solution and dried 1 minute at ambient temperature and then dipped in the PVP-solution used in Example 1. The catheters were further dried for 30 minutes at 70°C and exposed to UV-light at a wave length range between 200 and 300 nm. for 5 minutes.
- the friction coefficient of the hydrophilic coating was equivalent to that obtained with the single dip coating in Example 1 and 2.
- a primer coating layer with a high degree of crosslinking 5 parts of PVP K 90 was dissolved in 95 parts of a ethanol/gamma butyrolactone (85/15) solvent mixture. PVC catheters were dipped in the solution, dried for 30 minutes at 70°C and exposed to a UV light having a wave length between 200 and 300 nm for 10 minutes for providing a crosslinked primer coating layer.
- Example 6a Formation of a top coat layer with a lower degree of crosslinking:
- the catheters obtained in Example 6a) were dipped once again in the same solution, dried for 30 minutes at 70°C and exposed to a UV light having a wave length between 200 and 300 nm for only 5 minutes for providing a hydrophilic top coat layer having a lower degree of crosslinking and being easily swelleable.
- the catheter became lubricious when wetted and had a high abrasion resistance.
- a primer coating layer with a high degree of crosslinking 5 parts of PVP K 90 was dissolved in 95 parts of a ethanol/gamma butyrolactone (85/15) solvent mixture. PVC catheters were dipped in the solution, dried for 30 minutes at 70°C and exposed to a UV light having a wave length between 200 and 300 nm for 10 minutes for providing a crosslinked primer coating layer.
- Example 7a The catheters obtained in Example 7a) were dipped in a PVP-solution containing 5 parts of PVP, 1 part of urea and 94 parts of an ethanol/gamma butyrolactone (85/15) solvent mixture. The catheters were further dried for 30 minutes at 70°C and exposed to UV-light having a wave length range between 200 and 300 nm. for 5 minutes for providing a hydrophilic top coat layer having a different composition and having a lower degree of crosslinking and being easily swelleable.
- a PVP-solution containing 5 parts of PVP, 1 part of urea and 94 parts of an ethanol/gamma butyrolactone (85/15) solvent mixture.
- the catheters were further dried for 30 minutes at 70°C and exposed to UV-light having a wave length range between 200 and 300 nm. for 5 minutes for providing a hydrophilic top coat layer having a different composition and having a lower degree of crosslinking and being easily swelleable.
- the friction of the hydrophilic coating was determined as described above.
- the friction force of the coating prepared in Example 7 was lower than the friction force of coatings prepared by a single dipping procedure as disclosed in Example 1 , 2 and also lower than the friction force of a coating prepared according to Example 6.
- the friction force of the hydrophilic coating prepared according to Example 7 was comparable to the friction force of a coating prepared by the double dipping procedure according to Example 4 without intermediate curing of the first layer.
- the coatings of the invention in the form of two-layer coatings show friction forces of the same order of magnitude as not-crosslinked coatings whereas crosslinked coatings of the invention comprising urea clearly shows lower friction than not-crosslinked coatings comprising urea.
- PVC-catheters were dipped in a primer solution of 4 parts of a medical grade thermoplastic polyurethane and 2 parts of nitrocellulose dissolved in 94 parts of THF and afterwards dried in an oven for 15 minutes at 60°C.
- 4.0 parts of PVP K 90 was dissolved in 96 parts of an ethanol/gamma butyrolactone (85/15) solvent mixture and coated onto the PVC-catheters and dried 1 hour in an oven at 60°C.
- PVC-catheters were dipped in the PU/nitrocellulose primer solution as made in comparative Example A and dried for 15 minutes before they were dipped in the PVP-solution containing 3.36 parts of PVP K 90, 0.64 parts of urea and 96 parts of an ethanol/gamma butyrolactone (85/15) solvent mixture. The catheters were further dried 1 hour.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU80118/98A AU8011898A (en) | 1997-06-20 | 1998-06-19 | A hydrophilic coating and a method for the preparation thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK73297 | 1997-06-20 | ||
DK0732/97 | 1997-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998058990A1 true WO1998058990A1 (en) | 1998-12-30 |
Family
ID=8096912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1998/000265 WO1998058990A1 (en) | 1997-06-20 | 1998-06-19 | A hydrophilic coating and a method for the preparation thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU8011898A (en) |
WO (1) | WO1998058990A1 (en) |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002024246A1 (en) * | 2000-09-21 | 2002-03-28 | Hunter Urology Limited | Catheter with hydrophilic coating comprising an anthraquinone |
US6626829B1 (en) * | 2002-03-05 | 2003-09-30 | Eddie W. Skaggs | Laryngoscope and method |
US6634498B2 (en) | 1996-09-18 | 2003-10-21 | Coloplast A/S | Ready-to-use urinary catheter assembly |
WO2004075944A2 (en) | 2003-02-26 | 2004-09-10 | Coloplast A/S | A medical device having a coating comprising hydrogen peroxide and package therefore |
WO2006002628A1 (en) * | 2004-06-30 | 2006-01-12 | Coloplast A/S | A hydrophilic, water-swellable, cross-linked matrix having incorporated therein an anti-microbial polymer |
US6986868B2 (en) | 1998-11-20 | 2006-01-17 | Coloplast A/S | Method for sterilizing a medical device having a hydrophilic coating |
EP1688470A1 (en) * | 2005-02-04 | 2006-08-09 | Bioservice S.p.A. | Hydrophilic coated products and process for their production |
US7094220B2 (en) | 2001-06-29 | 2006-08-22 | Coloplast A/S | Catheter assembly including a catheter applicator |
WO2006093725A1 (en) * | 2005-02-28 | 2006-09-08 | Johnson & Johnson Vision Care, Inc. | Methods for providing biomedical devices with hydrophilic antimicrobial coatings |
WO2006117372A1 (en) * | 2005-05-02 | 2006-11-09 | Coloplast A/S | A method for sterilising a medical device having a hydrophilic coating |
DE10053554B4 (en) * | 2000-10-28 | 2007-07-05 | Fresenius Medical Care Deutschland Gmbh | Coating method for increasing the heat resistance and hydrophilization of the surfaces of substrates and thus obtained workpieces |
US7311698B2 (en) | 2001-09-24 | 2007-12-25 | Coloplast A/S | Urinary catheter assembly allowing for non-contaminated insertion of the catheter into a urinary canal |
WO2008074838A1 (en) * | 2006-12-21 | 2008-06-26 | Novartis Ag | Process for the coating of biomedical articles |
WO2007089784A3 (en) * | 2006-02-01 | 2008-07-31 | Hollister Inc | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
EP1961429A2 (en) | 1998-11-20 | 2008-08-27 | Coloplast A/S | A method for sterilising a medical device having a hydrophilic coating |
US7517343B2 (en) | 2001-06-29 | 2009-04-14 | Coloplast A/S | Catheter assembly |
WO2009070429A1 (en) * | 2007-11-29 | 2009-06-04 | Bausch & Lomb Incorporated | Process for making biomedical devices |
US7666935B2 (en) | 2004-10-08 | 2010-02-23 | Basf Se | Stabilisation of aqueous solutions of homopolymers and copolymers of N-vinylpyrrolidones |
EP2305744A1 (en) | 2002-12-20 | 2011-04-06 | Coloplast A/S | A hydrophilic coating and a method for the preparation |
US8158106B2 (en) | 2001-10-05 | 2012-04-17 | Surmodics, Inc. | Particle immobilized coatings and uses thereof |
US8241921B2 (en) | 2006-06-28 | 2012-08-14 | Surmodics, Inc. | Active agent eluting matrices with particulates |
US20130008029A1 (en) * | 2010-06-01 | 2013-01-10 | The King Of Shaves Company Ltd | Razors and razor blade cartridges and methods of manufacture therefore |
WO2014149321A1 (en) * | 2013-03-15 | 2014-09-25 | American Sterilizer Company | Reactive surface coating having chemical decontamination and biocidal properties |
KR20170000081A (en) | 2015-06-23 | 2017-01-02 | (주)헵틸와이 | Medical catheter comprising hydrophilic oxidized polysaccharide coating layer and manufacturing method thereof |
US9585784B2 (en) | 2011-08-29 | 2017-03-07 | Coloplast A/S | Catheter activation by handle removal |
EP2613819B1 (en) | 2010-09-08 | 2018-01-10 | Biointeractions Ltd. | Lubricious coatings for medical devices |
US9919154B2 (en) | 2015-12-18 | 2018-03-20 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10300276B2 (en) | 2015-05-28 | 2019-05-28 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10441454B2 (en) | 2001-06-29 | 2019-10-15 | Coloplast A/S | Urinary catheter provided as a package |
US10517999B2 (en) | 2016-04-12 | 2019-12-31 | Cardiac Pacemakers, Inc. | Hydrophilic coatings through in situ surface polymerization |
US10532209B2 (en) | 2015-12-18 | 2020-01-14 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10617789B2 (en) | 2015-04-16 | 2020-04-14 | Hollister Incorporated | Hydrophilic coatings and methods of forming the same |
US10646712B2 (en) | 2017-09-13 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus |
US10646718B2 (en) | 2016-11-15 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US10806936B2 (en) | 2015-11-20 | 2020-10-20 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US20210052783A1 (en) * | 2018-02-20 | 2021-02-25 | Qura, Inc. | Coatings for implantable devices |
CN113286851A (en) * | 2019-01-15 | 2021-08-20 | 艾维恩股份有限公司 | Lubricated thermoplastic compound and thermoplastic articles made therefrom |
US11097095B2 (en) | 2017-04-11 | 2021-08-24 | Advanced Bionics Ag | Cochlear implants, magnets for use with same and magnet retrofit methods |
US11167064B2 (en) | 2016-07-14 | 2021-11-09 | Hollister Incorporated | Hygienic medical devices having hydrophilic coating |
CN114246991A (en) * | 2021-11-19 | 2022-03-29 | 张家港市欧凯医疗器械有限公司 | Hydrophilic coating of medical pipeline |
US11287495B2 (en) | 2017-05-22 | 2022-03-29 | Advanced Bionics Ag | Methods and apparatus for use with cochlear implants having magnet apparatus with magnetic material particles |
US11364384B2 (en) | 2017-04-25 | 2022-06-21 | Advanced Bionics Ag | Cochlear implants having impact resistant MRI-compatible magnet apparatus |
CN114699564A (en) * | 2022-04-20 | 2022-07-05 | 威高集团有限公司 | Adhesion-enhanced lubricating coating, application thereof and medical interventional catheter |
CN115120788A (en) * | 2022-05-17 | 2022-09-30 | 上海全安医疗器械有限公司 | Medical hydrophilic coating solution and coating method thereof |
US11471679B2 (en) | 2017-10-26 | 2022-10-18 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11638823B2 (en) | 2018-02-15 | 2023-05-02 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11806650B2 (en) | 2016-08-16 | 2023-11-07 | Donaldson Company, Inc. | Hydrocarbon fluid-water separation |
US12017161B2 (en) | 2018-02-15 | 2024-06-25 | Donaldson Company, Inc. | Filter media configurations |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3089252A1 (en) * | 2018-02-15 | 2019-08-22 | Donaldson Company, Inc. | Substrate treatments |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4373009A (en) * | 1981-05-18 | 1983-02-08 | International Silicone Corporation | Method of forming a hydrophilic coating on a substrate |
EP0289996A2 (en) * | 1987-05-06 | 1988-11-09 | Wilkinson Sword Gesellschaft mit beschränkter Haftung | Process for the production of a hydrophilic coating on a moulded part, and razor manufactured by applying the process |
WO1989009246A1 (en) * | 1988-03-23 | 1989-10-05 | E.I. Du Pont De Nemours And Company | Low coefficient of friction surface |
-
1998
- 1998-06-19 WO PCT/DK1998/000265 patent/WO1998058990A1/en active Application Filing
- 1998-06-19 AU AU80118/98A patent/AU8011898A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4373009A (en) * | 1981-05-18 | 1983-02-08 | International Silicone Corporation | Method of forming a hydrophilic coating on a substrate |
EP0289996A2 (en) * | 1987-05-06 | 1988-11-09 | Wilkinson Sword Gesellschaft mit beschränkter Haftung | Process for the production of a hydrophilic coating on a moulded part, and razor manufactured by applying the process |
WO1989009246A1 (en) * | 1988-03-23 | 1989-10-05 | E.I. Du Pont De Nemours And Company | Low coefficient of friction surface |
Cited By (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6634498B2 (en) | 1996-09-18 | 2003-10-21 | Coloplast A/S | Ready-to-use urinary catheter assembly |
EP1961429A2 (en) | 1998-11-20 | 2008-08-27 | Coloplast A/S | A method for sterilising a medical device having a hydrophilic coating |
US9138510B2 (en) | 1998-11-20 | 2015-09-22 | Coloplast A/S | Sterilized ready-to-use catheter |
EP2065061A2 (en) | 1998-11-20 | 2009-06-03 | Coloplast A/S | A method for sterilising a medical device having a hydrophilic coating |
US6986868B2 (en) | 1998-11-20 | 2006-01-17 | Coloplast A/S | Method for sterilizing a medical device having a hydrophilic coating |
EP1961429A3 (en) * | 1998-11-20 | 2008-09-24 | Coloplast A/S | A method for sterilising a medical device having a hydrophilic coating |
WO2002024246A1 (en) * | 2000-09-21 | 2002-03-28 | Hunter Urology Limited | Catheter with hydrophilic coating comprising an anthraquinone |
DE10053554B4 (en) * | 2000-10-28 | 2007-07-05 | Fresenius Medical Care Deutschland Gmbh | Coating method for increasing the heat resistance and hydrophilization of the surfaces of substrates and thus obtained workpieces |
US7517343B2 (en) | 2001-06-29 | 2009-04-14 | Coloplast A/S | Catheter assembly |
EP2269682A1 (en) | 2001-06-29 | 2011-01-05 | Coloplast A/S | A catheter device |
EP2105158A2 (en) | 2001-06-29 | 2009-09-30 | Coloplast A/S | A catheter device |
US7094220B2 (en) | 2001-06-29 | 2006-08-22 | Coloplast A/S | Catheter assembly including a catheter applicator |
US10441454B2 (en) | 2001-06-29 | 2019-10-15 | Coloplast A/S | Urinary catheter provided as a package |
US7311698B2 (en) | 2001-09-24 | 2007-12-25 | Coloplast A/S | Urinary catheter assembly allowing for non-contaminated insertion of the catheter into a urinary canal |
US8679454B2 (en) | 2001-10-05 | 2014-03-25 | Surmodics, Inc. | Particle immobilized coatings and uses thereof |
US8158106B2 (en) | 2001-10-05 | 2012-04-17 | Surmodics, Inc. | Particle immobilized coatings and uses thereof |
US6626829B1 (en) * | 2002-03-05 | 2003-09-30 | Eddie W. Skaggs | Laryngoscope and method |
US8728508B2 (en) | 2002-12-20 | 2014-05-20 | Coloplast A/S | Hydrophilic coating and a method for the preparation thereof |
EP2305744A1 (en) | 2002-12-20 | 2011-04-06 | Coloplast A/S | A hydrophilic coating and a method for the preparation |
US20060263404A1 (en) * | 2003-02-26 | 2006-11-23 | Nielsen Bo R | Assembly for the preparation of a medical device having a coating comprising hydrogen peroxide |
WO2004075944A2 (en) | 2003-02-26 | 2004-09-10 | Coloplast A/S | A medical device having a coating comprising hydrogen peroxide and package therefore |
US9028858B2 (en) * | 2003-02-26 | 2015-05-12 | Coloplast A/S | Assembly for the preparation of a medical device having a coating comprising hydrogen peroxide |
WO2006002628A1 (en) * | 2004-06-30 | 2006-01-12 | Coloplast A/S | A hydrophilic, water-swellable, cross-linked matrix having incorporated therein an anti-microbial polymer |
US7666935B2 (en) | 2004-10-08 | 2010-02-23 | Basf Se | Stabilisation of aqueous solutions of homopolymers and copolymers of N-vinylpyrrolidones |
EP1688470A1 (en) * | 2005-02-04 | 2006-08-09 | Bioservice S.p.A. | Hydrophilic coated products and process for their production |
WO2006093725A1 (en) * | 2005-02-28 | 2006-09-08 | Johnson & Johnson Vision Care, Inc. | Methods for providing biomedical devices with hydrophilic antimicrobial coatings |
US7833475B2 (en) | 2005-05-02 | 2010-11-16 | Coloplast A/S | Method for sterilising a medical device having a hydrophilic coating |
WO2006117372A1 (en) * | 2005-05-02 | 2006-11-09 | Coloplast A/S | A method for sterilising a medical device having a hydrophilic coating |
JP2009525176A (en) * | 2006-02-01 | 2009-07-09 | ホリスター・インコーポレイテッド | Method for applying hydrophilic coating to substrate and substrate having hydrophilic coating |
US8053030B2 (en) | 2006-02-01 | 2011-11-08 | Hollister Incorporated | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
EP2289573B1 (en) | 2006-02-01 | 2016-10-26 | Hollister Incorporated | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
US10780199B2 (en) | 2006-02-01 | 2020-09-22 | Hollister Incorporated | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
US8377559B2 (en) | 2006-02-01 | 2013-02-19 | Hollister Incorporated | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
EP2289573A3 (en) * | 2006-02-01 | 2011-05-18 | Hollister Incorporated | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
WO2007089784A3 (en) * | 2006-02-01 | 2008-07-31 | Hollister Inc | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
EP1979016B1 (en) | 2006-02-01 | 2015-07-01 | Hollister Incorporated | Methods of applying a hydrophilic coating to a substrate, and substrates having a hydrophilic coating |
US8241921B2 (en) | 2006-06-28 | 2012-08-14 | Surmodics, Inc. | Active agent eluting matrices with particulates |
WO2008074838A1 (en) * | 2006-12-21 | 2008-06-26 | Novartis Ag | Process for the coating of biomedical articles |
JP2010513966A (en) * | 2006-12-21 | 2010-04-30 | ノバルティス アーゲー | Method for coating biomedical articles |
US8158192B2 (en) * | 2006-12-21 | 2012-04-17 | Novartis Ag | Process for the coating of biomedical articles |
WO2009070429A1 (en) * | 2007-11-29 | 2009-06-04 | Bausch & Lomb Incorporated | Process for making biomedical devices |
US10836878B2 (en) * | 2010-06-01 | 2020-11-17 | SOCIéTé BIC | Razors and razor blade cartridges and methods of manufacture therefore |
US20130008029A1 (en) * | 2010-06-01 | 2013-01-10 | The King Of Shaves Company Ltd | Razors and razor blade cartridges and methods of manufacture therefore |
EP2613819B1 (en) | 2010-09-08 | 2018-01-10 | Biointeractions Ltd. | Lubricious coatings for medical devices |
US9585784B2 (en) | 2011-08-29 | 2017-03-07 | Coloplast A/S | Catheter activation by handle removal |
JP2016520513A (en) * | 2013-03-15 | 2016-07-14 | アメリカン ステリライザー カンパニー | Reactive surface coating with chemical decontamination performance and biocidal properties |
US9353269B2 (en) | 2013-03-15 | 2016-05-31 | American Sterilizer Company | Reactive surface coating having chemical decontamination and biocidal properties |
JP2017128584A (en) * | 2013-03-15 | 2017-07-27 | アメリカン ステリライザー カンパニー | Reactive surface coating with chemical decontamination performance and biocidal properties |
EP2967031A4 (en) * | 2013-03-15 | 2016-08-17 | American Sterilizer Co | REACTIVE SURFACE COATING HAVING CHEMICAL DECONTAMINATION AND BIOCID PROPERTIES |
WO2014149321A1 (en) * | 2013-03-15 | 2014-09-25 | American Sterilizer Company | Reactive surface coating having chemical decontamination and biocidal properties |
CN105101794A (en) * | 2013-03-15 | 2015-11-25 | 美国消毒器公司 | Reactive surface coating having chemical decontamination and biocidal properties |
US11623020B2 (en) | 2015-04-16 | 2023-04-11 | Hollister Incorporated | Hydrophilic coatings and methods of forming the same |
US10617789B2 (en) | 2015-04-16 | 2020-04-14 | Hollister Incorporated | Hydrophilic coatings and methods of forming the same |
US10300276B2 (en) | 2015-05-28 | 2019-05-28 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
KR20170000081A (en) | 2015-06-23 | 2017-01-02 | (주)헵틸와이 | Medical catheter comprising hydrophilic oxidized polysaccharide coating layer and manufacturing method thereof |
US10806936B2 (en) | 2015-11-20 | 2020-10-20 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US10532209B2 (en) | 2015-12-18 | 2020-01-14 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US11476025B2 (en) | 2015-12-18 | 2022-10-18 | Advanced Bionics Ag | MRI-compatible magnet apparatus |
US10463849B2 (en) | 2015-12-18 | 2019-11-05 | Advanced Bionics Ag | MRI-compatible magnet apparatus and associated methods |
US10821279B2 (en) | 2015-12-18 | 2020-11-03 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US9919154B2 (en) | 2015-12-18 | 2018-03-20 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US11986656B2 (en) | 2015-12-18 | 2024-05-21 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus and associated methods |
US10517999B2 (en) | 2016-04-12 | 2019-12-31 | Cardiac Pacemakers, Inc. | Hydrophilic coatings through in situ surface polymerization |
US12318511B2 (en) | 2016-07-14 | 2025-06-03 | Hollister Incorporated | Hygienic medical devices having hydrophilic coatings and methods of forming the same |
US11167064B2 (en) | 2016-07-14 | 2021-11-09 | Hollister Incorporated | Hygienic medical devices having hydrophilic coating |
US11806650B2 (en) | 2016-08-16 | 2023-11-07 | Donaldson Company, Inc. | Hydrocarbon fluid-water separation |
US10646718B2 (en) | 2016-11-15 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants and magnets for use with same |
US11097095B2 (en) | 2017-04-11 | 2021-08-24 | Advanced Bionics Ag | Cochlear implants, magnets for use with same and magnet retrofit methods |
US11779754B2 (en) | 2017-04-11 | 2023-10-10 | Advanced Bionics Ag | Cochlear implants, magnets for use with same and magnet retrofit methods |
US11364384B2 (en) | 2017-04-25 | 2022-06-21 | Advanced Bionics Ag | Cochlear implants having impact resistant MRI-compatible magnet apparatus |
US11752338B2 (en) | 2017-04-25 | 2023-09-12 | Advanced Bionics Ag | Cochlear implants having impact resistant MRI-compatible magnet apparatus |
US11287495B2 (en) | 2017-05-22 | 2022-03-29 | Advanced Bionics Ag | Methods and apparatus for use with cochlear implants having magnet apparatus with magnetic material particles |
US10646712B2 (en) | 2017-09-13 | 2020-05-12 | Advanced Bionics Ag | Cochlear implants having MRI-compatible magnet apparatus |
US12350493B2 (en) | 2017-10-26 | 2025-07-08 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11471679B2 (en) | 2017-10-26 | 2022-10-18 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US11638823B2 (en) | 2018-02-15 | 2023-05-02 | Advanced Bionics Ag | Headpieces and implantable cochlear stimulation systems including the same |
US12017161B2 (en) | 2018-02-15 | 2024-06-25 | Donaldson Company, Inc. | Filter media configurations |
US20210052783A1 (en) * | 2018-02-20 | 2021-02-25 | Qura, Inc. | Coatings for implantable devices |
US11684703B2 (en) * | 2018-02-20 | 2023-06-27 | Qura, Inc. | Coatings for implantable devices |
CN113286851A (en) * | 2019-01-15 | 2021-08-20 | 艾维恩股份有限公司 | Lubricated thermoplastic compound and thermoplastic articles made therefrom |
US12351773B2 (en) | 2019-01-15 | 2025-07-08 | Avient Corporation | Lubricious thermoplastic compounds and thermoplastic articles made therefrom |
CN114246991A (en) * | 2021-11-19 | 2022-03-29 | 张家港市欧凯医疗器械有限公司 | Hydrophilic coating of medical pipeline |
CN114699564A (en) * | 2022-04-20 | 2022-07-05 | 威高集团有限公司 | Adhesion-enhanced lubricating coating, application thereof and medical interventional catheter |
CN115120788A (en) * | 2022-05-17 | 2022-09-30 | 上海全安医疗器械有限公司 | Medical hydrophilic coating solution and coating method thereof |
CN115120788B (en) * | 2022-05-17 | 2023-07-18 | 上海全安医疗器械有限公司 | Medical hydrophilic coating solution and coating method thereof |
Also Published As
Publication number | Publication date |
---|---|
AU8011898A (en) | 1999-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998058990A1 (en) | A hydrophilic coating and a method for the preparation thereof | |
EP0991701B1 (en) | A hydrophilic coating and a method for the preparation thereof | |
EP0991702B2 (en) | A hydrophilic coating | |
JP5432528B2 (en) | Method for applying hydrophilic coating to substrate and substrate having hydrophilic coating | |
CN100467516C (en) | A hydrophilic coating and a method for the preparation thereof | |
JP4602556B2 (en) | Method for sterilizing medical devices having a hydrophilic coating | |
EP1667747B1 (en) | Lubricious coatings for medical device | |
JP5501344B2 (en) | Improved medical device having a hydrophilic coating | |
DK2198897T3 (en) | PROCESS FOR THE PREPARATION OF A medical device having a crosslinked hydrophilic coating | |
JP2012504995A (en) | Medical devices with controlled-release antibacterial agents | |
EP3503934B1 (en) | Methods of selectively modifying the flexibility of medical tubes | |
JP2025087670A (en) | UV curable coating for medical devices | |
US20100100009A1 (en) | Device Having a Hydrophilic Coating Comprising P-Toluene-Sulfonamide and a Method for the Preparation Thereof | |
AU2003200387C1 (en) | A method for sterilising a medical device having a hydrophilic coating |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1999503612 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |